NovoLog FlexPen and Sodium zirconium cyclosilicate
Determining the interaction of NovoLog FlexPen and Sodium zirconium cyclosilicate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: n.a.
Generic Name: sodium zirconium cyclosilicate
Brand name: Lokelma
Synonyms: Sodium Zirconium Cyclosilicate
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- NovoLog FlexPen-Sofosbuvir
- NovoLog FlexPen-Sofosbuvir and velpatasvir
- NovoLog FlexPen-Sofosbuvir Tablets
- NovoLog FlexPen-Sofosbuvir, velpatasvir, and voxilaprevir
- NovoLog FlexPen-Sojourn
- NovoLog FlexPen-Sojourn Inhalant
- Sodium zirconium cyclosilicate-Novolog Injection
- Sodium zirconium cyclosilicate-NovoLog Mix 70/30
- Sodium zirconium cyclosilicate-NovoLog Mix 70/30 (Insulin Aspart Protamine and Insulin Aspart (Cartridges and Prefilled Pens))
- Sodium zirconium cyclosilicate-NovoLog Mix 70/30 (Insulin Aspart Protamine and Insulin Aspart (Vials))
- Sodium zirconium cyclosilicate-NovoLog Mix 70/30 FlexPen
- Sodium zirconium cyclosilicate-NovoLog PenFill